mark gordon liposomal glutathione Gautam Borthakur Frontiers | Glutathione and neurodegenerative

Early evidence for the potential efficacy of this route was published in 1999, where 18 patients with B12 deficiency treated exclusively with 712 days of 2 mg of sublingual cobalamin daily had 4 times higher B12 levels compared to pre-treatment, reaching therapeutic ranges ( There have also been further studies comparing treatment outcomes from the sublingual route to the more established IM and oral routes

Kovanda et al., 2019

A: A synthetic peptide representing the active region of Thymosin Beta-4 (amino acids 17-23 of the naturally occurring 43-AA peptide) believed responsible for most of its biological activity in research models

Highlight compounds 20 25 proved to be potential XO and/or COX inhibitors in vitro, with the most potent XO inhibitor exhibiting an IC 50 value of 9 nM, being more potent than febuxostat (26 nM), used as a standard (Table 1)